Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Vessel co-option and radioresistance in glioblastoma

Descripción del proyecto

Una visión mecanística de la radiorresistencia en el glioblastoma

El glioblastoma es un tumor encefálico de gran malignidad con una alta tasa de recidiva incluso tras una resección quirúrgica, quimioterapia y radioterapia. Esto se ha atribuido a las células que desencadenan el glioma, que parecen residir en el espacio perivascular y son resistentes a la quimioterapia y la radiación. El proyecto financiado con fondos europeos VESSEL CO-COPTION investigará la hipótesis de que estas células madre adquieren radiorresistencia recorriendo la vasculatura preexistente a través de un proceso conocido como cooptación vascular, que constituye una alternativa a la angiogénesis. Mediante avanzados métodos, los científicos descifrarán el mecanismo mediante el cual las células madre del glioma adquieren resistencia a la radioterapia. Los datos obtenidos permitirán mejorar esa línea de tratamiento.

Objetivo

Glioblastoma (GBM) is one of the deadliest types of human cancer. Despite a very aggressive treatment regime – including resection of the tumor, radiation and chemotherapy – its estimated recurrence rate is more than 90%. Recurrence is mostly caused by the regrowth of highly invasive cells spreading from the tumor bulk, which are not removed by resection. To develop an effective therapeutic approach, we need to better understand the underlying molecular mechanism of radiation resistance and tumor spreading in GBM.
Radioresistance in GBM is attributed to glioma stem cells (GSCs), a fraction of perivascular, self-renewing, multipotent and tumor-initiating cells. Growing evidence highlights the perivascular space as a niche for GSC survival, resistance to therapy, progression and dissemination. The unknown factor is the dynamics of GSCs, how they end up in the vascular niche and how this impacts on radioresistance.
My overall hypothesis is that GSCs reach the perivascular niche through vessel co-option - the directional migration of tumor cells towards vessels - and that targeting vessel co-option has the potential to radiosensitize GBM.
With this project, we aim to uncover the exact molecular and cellular connections among vessel co-option, GSCs, the vascular niche and radioresistance. Using multiple strategies, such as multiphoton intravital microscopy, orthotopic models of GBM, organotypic cultures, screenings and survival studies, we will investigate and mechanistically change the dynamics of GSC and differentiated GBM cells in order to understand the role of their interaction with brain vessels and whether this confers resistance to radiotherapy.
These studies will provide clinically relevant insights into the involvement of GSCs, the vascular niche and vessel co-option in the resistance of GBM to therapy. Since all GBM patients receive radiotherapy, many would benefit from therapeutic strategies aimed at increasing its efficacy.

Ámbito científico (EuroSciVoc)

CORDIS clasifica los proyectos con EuroSciVoc, una taxonomía plurilingüe de ámbitos científicos, mediante un proceso semiautomático basado en técnicas de procesamiento del lenguaje natural.

Para utilizar esta función, debe iniciar sesión o registrarse

Régimen de financiación

ERC-STG - Starting Grant

Institución de acogida

INSTITUT CURIE
Aportación neta de la UEn
€ 1 105 604,25
Dirección
RUE D ULM 26
75231 Paris
Francia

Ver en el mapa

Región
Ile-de-France Ile-de-France Paris
Tipo de actividad
Research Organisations
Enlaces
Coste total
€ 1 499 823,00

Beneficiarios (2)